The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Potassium Citrate and Citric Acid
Potassium Citrate and Citric Acid · POTASSIUM CITRATE 1100 mg/5mL; CITRIC ACID MONOHYDRATE 334 mg/5mL · Solution · Oral · Chartwell RX, LLC
NDC 62135-0435-24 · 2 TRAY in 1 BOX / 10 CUP in 1 TRAY / 5 mL in 1 CUP · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$1,863.42
Reported to Texas DSHS · 2026 annual filing · Chartwell RX, LLC
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for potassium citrate and citric acid (other) in the next 90 days
price up 12% YoY · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Chartwell Pharmaceuticals Carmel, LLC.United Statesanalysis · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Xywav and Xyrem
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Potassium Citrate and Citric Acid (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Chartwell Governmental & Specialty RX, LLC. | POTASSIUM CITRATE 1100 mg/5mL; CITRIC ACID MONOHYDRATE 334 mg/5mL | Aug 26, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | POTASSIUM CITRATE 1100 mg/5mL; CITRIC ACID MONOHYDRATE 334 mg/5mL | Aug 26, 2026 | Sep 2, 2026 |
| Chartwell Governmental & Specialty RX, LLC. | POTASSIUM CITRATE 334 mg/5mL; CITRIC ACID MONOHYDRATE 1100 mg/5mL | Jul 22, 2026 | Aug 19, 2026 |
| Chartwell RX, LLC | POTASSIUM CITRATE 334 mg/5mL; CITRIC ACID MONOHYDRATE 1100 mg/5mL | Jul 22, 2026 | Aug 19, 2026 |
| Chartwell Governmental & Specialty RX, LLC. | CITRIC ACID MONOHYDRATE 334 mg/5mL; POTASSIUM CITRATE 1100 mg/5mL | Jul 15, 2026 | Jul 15, 2026 |
| Chartwell RX, LLC | CITRIC ACID MONOHYDRATE 334 mg/5mL; POTASSIUM CITRATE 1100 mg/5mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Potassium Citrate and Citric Acid — NDC 62135-0435-24," retrieved September 3, 2026, https://drugdashboards.com/drug/62135043524.
Free to cite with attribution — see how the data is put together.